Hirudin attenuates puromycin aminonucleoside‐induced glomerular podocyte injury by inhibiting MAPK‐mediated endoplasmic reticulum stress
Authors:
- 11 March 2022
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 83 (4) , 1047-1056
Abstract
Damage to podocytes is an important determinant of renal pathology. The puromycin aminonucleoside (PAN) mice nephropathy model is commonly used in the study of renal disease with podocyte injury. Hirudin has a broad nephroprotective effect and has been shown to treat renal interstitial fibrosis in previous studies. Mice were given PAN by gavage to prepare animal models, and MPC5 cells were incubated with PAN in vitro. Twenty‐four hours urine was collected for analysis of urinary protein levels. Renal pathological changes were observed by hematoxylin and eosin staining. Immunofluorescence detection of nephrin in kidney tissues and cells. Apoptosis was analyzed with over TUNEL. Cytoskeleton, endoplasmic reticulum stress (ERS), p38 MAPK signaling, and apoptosis‐related proteins were assessed by western blot analysis. The data suggested that hirudin attenuated reduced renal injury and increased urine protein in PAN mice. Hirudin also attenuated cytoskeletal protein (synaptopodin, nephrin, and podocin) disruption, ERS activation, and apoptosis in PAN mice and PAN‐induced podocytes. In addition, hirudin inhibited the expression of p38 MAPK signaling key proteins upregulated by PAN, thereby suppressing ERS. The p38 MAPK agonist was able to partially antagonize the inhibition of p38 MAPK signaling by hirudin in PAN‐induced podocytes, thereby reactivating the ERS inhibited by hirudin, promoting cytoskeletal protein degradation and increasing the level of apoptosis. In conclusion, hirudin could decrease podocyte injury by inhibiting p38 MAPK signaling‐mediated ERS, resulting in the protection of the kidney from PAN damage. These findings may provide an experimental basis for hirudin treatment of podocyte injury diseases.Keywords
Funding Information
- Natural Science Foundation of Guangxi Province (2020GXNSFAA259086)
- National Natural Science Foundation of China (82060804)
This publication has 36 references indexed in Scilit:
- Systemic administration of naked plasmid encoding HGF attenuates puromycin aminonucleoside-induced damage of murine glomerular podocytesAmerican Journal of Physiology-Renal Physiology, 2011
- Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistanceBMC Nephrology, 2010
- Apoptosis in the kidneys of patients with type II diabetic nephropathyKidney International, 2007
- Proteinuria with and without Renal Glomerular Podocyte EffacementJournal of the American Society of Nephrology, 2006
- TGF-β Concentration Specifies Differential Signaling Profiles of Growth Arrest/Differentiation and Apoptosis in PodocytesJournal of the American Society of Nephrology, 2005
- Role of p38 Mitogen-Activated Protein Kinase Activation in Podocyte Injury and Proteinuria in Experimental Nephrotic SyndromeJournal of the American Society of Nephrology, 2005
- Podocyte biology in human diseaseNephrology, 2005
- Viable Podocytes Detach in Experimental Diabetic Nephropathy: Potential Mechanism Underlying GlomerulosclerosisNephron Experimental Nephrology, 2004
- Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritisKidney International, 2003
- Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosisKidney International, 1996